- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/62 - Insulins
Patent holdings for IPC class C07K 14/62
Total number of patents in this class: 1065
10-year publication summary
|
78
|
89
|
86
|
99
|
90
|
82
|
73
|
72
|
70
|
37
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novo Nordisk A/S | 2283 |
68 |
| Case Western Reserve University | 1892 |
53 |
| Hanmi Pharm. Co., Ltd. | 602 |
38 |
| Modernatx, Inc. | 1292 |
34 |
| Merck Sharp & Dohme LLC | 3736 |
29 |
| Eli Lilly and Company | 4106 |
27 |
| Akston Biosciences Corporation | 49 |
18 |
| Sanofi-Aventis Deutschland GmbH | 2592 |
17 |
| Biocon Limited | 221 |
17 |
| Chemical & Biopharmaceutical Laboratories of Patras S.A. | 28 |
17 |
| Dechra Limited | 115 |
17 |
| Merck Sharp & Dohme Corp. | 2183 |
16 |
| Sanofi | 4307 |
16 |
| Ecole Polytechnique Federale de Lausanne (epfl) | 1609 |
14 |
| Protomer Technologies, Inc. | 20 |
13 |
| Quiapeg Pharmaceuticals AB | 38 |
12 |
| GAN & Lee Pharmaceuticals Co., Ltd. | 59 |
12 |
| Indiana University Research and Technology Corporation | 783 |
11 |
| Codexis, Inc. | 816 |
10 |
| The Trustees of Indiana University | 825 |
10 |
| Other owners | 616 |